GNF-5120

N/A

Report date: 2025/01/26 15:51:40
NME

Base Information

Drug NameGNF-5120
Drug Alias NameFarnesoid X receptor agonist (Novartis)GNF-5120
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBile acid receptor FXR agonists
TargetsBile acid receptor FXR
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver DiseaseCholangitis, Sclerosing
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNovartis Ag
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Ag
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver DiseaseCholangitis, Sclerosing
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A